Post-effective amendment to a registration statement that is not immediately effective upon filing

Note Payable - Additional Information (Detail)

v2.4.1.9
Note Payable - Additional Information (Detail) (USD $)
0 Months Ended 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended
Mar. 15, 2015
Mar. 31, 2015
Mar. 31, 2015
Mar. 31, 2014
Mar. 31, 2015
Mar. 31, 2014
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2013
Apr. 19, 2013
Note Payable [Line Items]                    
Notes Payable, Total   $ 944,707us-gaap_NotesPayable $ 944,707us-gaap_NotesPayable   $ 944,707us-gaap_NotesPayable   $ 944,707us-gaap_NotesPayable      
Adjustments to Additional Paid in Capital, Warrant Issued             55,293us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued      
Fair Value Assumptions, Expected Term 1 year 11 months 16 days                
Class of Warrant or Right, Exercise Price of Warrants or Rights                   $ 0.75us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Interest Expense, Debt     2,764us-gaap_InterestExpenseDebt 5,529us-gaap_InterestExpenseDebt 2,764us-gaap_InterestExpenseDebt 5,529us-gaap_InterestExpenseDebt 11,059us-gaap_InterestExpenseDebt      
Debt instrument, unamortized discount   961,295us-gaap_DebtInstrumentUnamortizedDiscount 961,295us-gaap_DebtInstrumentUnamortizedDiscount   961,295us-gaap_DebtInstrumentUnamortizedDiscount   955,766us-gaap_DebtInstrumentUnamortizedDiscount      
Warrant                    
Note Payable [Line Items]                    
Adjustments to Additional Paid in Capital, Warrant Issued     55,293us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_WarrantMember
             
Fair Value Assumptions, Risk Free Interest Rate         2.64%us-gaap_FairValueAssumptionsRiskFreeInterestRate
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_WarrantMember
  2.64%us-gaap_FairValueAssumptionsRiskFreeInterestRate
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_WarrantMember
     
Fair Value Assumptions, Expected Dividend Rate         0.00%us-gaap_FairValueAssumptionsExpectedDividendRate
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_WarrantMember
  0.00%us-gaap_FairValueAssumptionsExpectedDividendRate
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_WarrantMember
     
Fair Value Assumptions, Expected Term         10 years   10 years      
Fair Value Assumptions, Expected Volatility Rate         114.00%us-gaap_FairValueAssumptionsExpectedVolatilityRate
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_WarrantMember
  114.00%us-gaap_FairValueAssumptionsExpectedVolatilityRate
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_WarrantMember
     
Massachusetts Life Sciences Center                    
Note Payable [Line Items]                    
Subordinated Debt               $ 1,000,000us-gaap_SubordinatedDebt
/ dei_LegalEntityAxis
= arth_MassachusettsLifeSciencesCenterMember
$ 1,000,000us-gaap_SubordinatedDebt
/ dei_LegalEntityAxis
= arth_MassachusettsLifeSciencesCenterMember
 
Debt Instrument, Payment Terms               The loan bears interest at a rate of 10% per annum, and will become fully due and payable on the earlier of (i) September 30, 2018, (ii) the occurrence of an event of default under the MLSC Loan Agreement, or (iii) the completion of a sale of substantially all of our assets, a change-of-control transaction or one or more financing transactions in which we receive net proceeds of $5,000,000 or more in a 12-month period. The loan bears interest at a rate of 10% per annum, and will become fully due and payable on the earlier of (i) September 30, 2018, (ii) the occurrence of an event of default under the MLSC Loan Agreement, or (iii) the completion of a sale of substantially all of our assets, a change-of-control transaction or one or more financing transactions in which we receive net proceeds of $5,000,000 or more in a 12-month period.  
Warrants Issued To Purchase Of Common Stock               145,985arth_WarrantsIssuedToPurchaseOfCommonStock
/ dei_LegalEntityAxis
= arth_MassachusettsLifeSciencesCenterMember
145,985arth_WarrantsIssuedToPurchaseOfCommonStock
/ dei_LegalEntityAxis
= arth_MassachusettsLifeSciencesCenterMember
 
Class Of Warrant Or Right Expiration Date               Sep. 30, 2023 Sep. 30, 2023  
Class of Warrant or Right, Exercise Price of Warrants or Rights               $ 0.27us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
/ dei_LegalEntityAxis
= arth_MassachusettsLifeSciencesCenterMember
$ 0.27us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
/ dei_LegalEntityAxis
= arth_MassachusettsLifeSciencesCenterMember